Streetbeat News

Stock Prices

CNPOF

RIV Capital Inc. (OTC:CNPOF) reported a revenue increase to $2.1 million in CQ4 2023 from $1.9 million in CQ4 2022, driven by retail and wholesale sales of Etain-branded products in New York. Despite revenue growth, the company faced a gross loss of $0.6 million due to increased costs and an impairment charge of $48.7 million related to its acquisition of Etain, leading to a net loss of $47.3 million for CQ4 2023.

Portfolio Pulse from Rolando García

April 30, 2024 | 4:06 pm

NAUT

Nautilus Biotechnology's stock price increased following the announcement of their Q1 earnings per share (EPS) results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 4:03 pm

IBM

Investors have shown a bullish stance on IBM (NYSE:IBM), with options trading indicating a target price range of $110 to $200. Recent options activity includes 12 significant trades, with a sentiment split of 58% bullish and 41% bearish. The trading volume and open interest in IBM's options have been analyzed, highlighting substantial trades within the $110 to $200 strike price range. IBM's current market status shows a slight price decrease, with an earnings announcement expected in 78 days. Professional analysts have provided mixed ratings, with an average price target of $173.8.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

CVS

Deep-pocketed investors have shown a bullish trend in CVS Health (NYSE:CVS) options trading, with a significant portion of activity leaning towards bullish sentiments. Benzinga's options scanner revealed 12 extraordinary activities, with a price target range from $50.0 to $72.0. The trading includes both puts and calls, with the largest trades indicating a mix of bullish and bearish sentiments. CVS Health, a major healthcare services provider, has seen its stock price slightly down with analysts giving mixed reviews but generally positive price targets.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

RVTY

Analysts have updated their ratings and price targets for Revvity (NYSE:RVTY), showing a positive shift in sentiment with an average 12-month price target of $123.25, up 13.59% from the previous $108.50. The company, operating in diagnostics and discovery/analytical solutions, faces a revenue decline of -6.11% over the last 3 months but maintains a strong net margin of 11.29%. Despite challenges in revenue growth and ROE, Revvity's prudent debt management and profitability are highlighted.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:01 pm

NKE

Analyst ratings for Nike (NYSE:NKE) over the last quarter show a mix of bullish to bearish sentiments among 29 analysts, with a shift towards more conservative ratings in the last 30 days. The average 12-month price target for Nike is now $114.28, down 7.84% from the previous target, reflecting a cautious outlook from analysts. Recent actions include both downgrades and maintenance of ratings, with price targets adjusted accordingly. Nike's financial performance remains strong, with positive revenue growth, high net margin, and effective debt management, positioning it well in the athletic footwear and apparel industry.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:00 pm

JBL

Over the past 10 years, Jabil (NYSE:JBL) has produced an average annual return of 21.09%, outperforming the market by 10.6% annually. With a current market capitalization of $14.33 billion, a $1000 investment in JBL stock 10 years ago would be worth $6,761.24 today.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:00 pm

PDD

$100 invested in PDD Holdings (NASDAQ:PDD) 5 years ago would now be worth $525.75, showcasing an annualized return of 39.62% and outperforming the market by 28.05%. PDD Holdings currently has a market cap of $174.94 billion.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 4:00 pm

FTXN

IEO

MPC

MPLX

Marathon Petroleum Corporation (NYSE:MPC) shares fell after reporting Q1 FY24 results with revenue of $33.211 billion, surpassing estimates but with a decline in adjusted EBITDA to $3.26 billion from $5.22 billion year-over-year. Refining & Marketing segment adjusted EBITDA also dropped significantly due to lower market crack spreads and throughputs. Despite this, adjusted EPS was $2.78, above consensus. The company announced a $5 billion share repurchase authorization, adding to an existing $3.8 billion, and returned $2.2 billion through share repurchases and $299 million via dividends in Q1. MPLX LP (NYSE:MPLX), in which Marathon Petroleum holds a significant interest, reported earnings per limited partner unit of $0.98 on sales of $2.85 billion, missing estimates. MPC shares are down 6.6%.

Portfolio Pulse from Lekha Gupta

April 30, 2024 | 3:59 pm

CECO

CECO Environmental shares are trading lower following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 3:57 pm